Gut Serpinome: Emerging Evidence in IBD - Centre d’Etude des Pathologies Respiratoires (CEPR), UMR 1100 Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) International Journal of Molecular Sciences Année : 2021

Gut Serpinome: Emerging Evidence in IBD

Résumé

Inflammatory bowel diseases (IBD) are incurable disorders whose prevalence and global socioeconomic impact are increasing. While the role of host genetics and immunity is well documented, that of gut microbiota dysbiosis is increasingly being studied. However, the molecular basis of the dialogue between the gut microbiota and the host remains poorly understood. Increased activity of serine proteases is demonstrated in IBD patients and may contribute to the onset and the maintenance of the disease. The intestinal proteolytic balance is the result of an equilibrium between the proteases and their corresponding inhibitors. Interestingly, the serine protease inhibitors (serpins) encoded by the host are well reported; in contrast, those from the gut microbiota remain poorly studied. In this review, we provide a concise analysis of the roles of serine protease in IBD physiopathology and we focus on the serpins from the gut microbiota (gut serpinome) and their relevance as a promising therapeutic approach.
Fichier principal
Vignette du fichier
ijms-22-06088-v2.pdf (970.68 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03372010 , version 1 (06-12-2023)

Identifiants

Citer

Héla Mkaouar, Vincent Mariaule, Soufien Rhimi, Juan Hernandez, Aicha Kriaa, et al.. Gut Serpinome: Emerging Evidence in IBD. International Journal of Molecular Sciences, 2021, 22 (11), pp.6088. ⟨10.3390/ijms22116088⟩. ⟨hal-03372010⟩
92 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More